APO Research

APO RESEARCH · REPORT

Molecular Docking and Virtual Screening Software

Selected research

Market Structure

Global Molecular Docking and Virtual Screening Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Molecular Docking and Virtual Screening Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Molecular Docking and Virtual Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Molecular Docking and Virtual Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Molecular Docking and Virtual Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Molecular Docking and Virtual Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Molecular Docking and Virtual Screening Software include OpenEye Cadence Molecular Sciences, Cambridge Crystallographic Data Centre, Cresset, BioSolveIT, Molsoft, Molecular Discovery, DP Technology, XtalPi and Schrödinger, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Molecular Docking and Virtual Screening Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Molecular Docking and Virtual Screening Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Molecular Docking and Virtual Screening Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Molecular Docking and Virtual Screening Software market size, projected growth trends, production technologies, key applications, and end-use industries.

Molecular Docking and Virtual Screening Software Segment by Company

OpenEye Cadence Molecular Sciences

Cambridge Crystallographic Data Centre

Cresset

BioSolveIT

Molsoft

Molecular Discovery

DP Technology

XtalPi

Schrödinger

Dassault Systèmes

Chemical Computing Group

Molecular Docking and Virtual Screening Software Segment by Type

Structure-Based Docking Software

Ligand-Based Screening Software

Pharmacophore Screening Software

Shape and Electrostatic Similarity Software

AI-Assisted Docking Software

Molecular Docking and Virtual Screening Software Segment by Application

Hit Discovery

Lead Optimization

Drug Repurposing

Fragment-Based Drug Design

Target Validation and Mechanism Study

Teaching and Academic Research

Molecular Docking and Virtual Screening Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Docking and Virtual Screening Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Docking and Virtual Screening Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Docking and Virtual Screening Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Molecular Docking and Virtual Screening Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Molecular Docking and Virtual Screening Software industry.

Chapter 3: Detailed analysis of Molecular Docking and Virtual Screening Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Docking and Virtual Screening Softwarerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Structure-Based Docking Software Table 3. Key Players of Ligand-Based Screening Software Table 4. Key Players of Pharmacophore Screening Software Table 3. Key Players of Shape and Electrostatic Similarity Software Table 4. Key Players of AI-Assisted Docking Software Table 5. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hit Discovery Table 7. Key Players of Lead Optimization Table 8. Key Players of Drug Repurposing Table 9. Key Players of Fragment-Based Drug Design Table 10. Key Players of Target Validation and Mechanism Study Table 11. Key Players of Teaching and Academic Research Table 12. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Molecular Docking and Virtual Screening Software Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Molecular Docking and Virtual Screening Software Market Share by Region (2021-2026) Table 15. Global Molecular Docking and Virtual Screening Software Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Molecular Docking and Virtual Screening Software Market Share by Region (2027-2032) Table 17. Molecular Docking and Virtual Screening Software Industry Trends Table 18. Molecular Docking and Virtual Screening Software Industry Drivers Table 19. Molecular Docking and Virtual Screening Software Industry Opportunities and Challenges Table 20. Molecular Docking and Virtual Screening Software Industry Restraints Table 21. Global Molecular Docking and Virtual Screening Software Revenue by Company (US$ Million) & (2021-2026) Table 22. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Company (2021-2026) Table 23. Global Molecular Docking and Virtual Screening Software Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 24. Global Molecular Docking and Virtual Screening Software Key Company Head Office and Area Served Table 25. Global Molecular Docking and Virtual Screening Software Company, Product Type & Application Table 26. Global Molecular Docking and Virtual Screening Software Company Establishment Date Table 27. Global Company Market Concentration Ratio (CR5 and HHI) Table 28. Global Molecular Docking and Virtual Screening Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 29. Global Molecular Docking and Virtual Screening Software Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million) Table 31. Global Molecular Docking and Virtual Screening Software Market Size by Type (2027-2032) & (US$ Million) Table 32. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Type (2021-2026) Table 33. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Type (2027-2032) Table 34. Global Molecular Docking and Virtual Screening Software Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million) Table 36. Global Molecular Docking and Virtual Screening Software Market Size by Application (2027-2032) & (US$ Million) Table 37. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Application (2021-2026) Table 38. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Application (2027-2032) Table 39. OpenEye Cadence Molecular Sciences Company Information Table 40. OpenEye Cadence Molecular Sciences Business Overview Table 41. OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Product Portfolio Table 43. OpenEye Cadence Molecular Sciences Recent Development Table 44. Cambridge Crystallographic Data Centre Company Information Table 45. Cambridge Crystallographic Data Centre Business Overview Table 46. Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Product Portfolio Table 48. Cambridge Crystallographic Data Centre Recent Development Table 49. Cresset Company Information Table 50. Cresset Business Overview Table 51. Cresset Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Cresset Molecular Docking and Virtual Screening Software Product Portfolio Table 53. Cresset Recent Development Table 54. BioSolveIT Company Information Table 55. BioSolveIT Business Overview Table 56. BioSolveIT Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. BioSolveIT Molecular Docking and Virtual Screening Software Product Portfolio Table 58. BioSolveIT Recent Development Table 59. Molsoft Company Information Table 60. Molsoft Business Overview Table 61. Molsoft Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Molsoft Molecular Docking and Virtual Screening Software Product Portfolio Table 63. Molsoft Recent Development Table 64. Molecular Discovery Company Information Table 65. Molecular Discovery Business Overview Table 66. Molecular Discovery Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Molecular Discovery Molecular Docking and Virtual Screening Software Product Portfolio Table 68. Molecular Discovery Recent Development Table 69. DP Technology Company Information Table 70. DP Technology Business Overview Table 71. DP Technology Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. DP Technology Molecular Docking and Virtual Screening Software Product Portfolio Table 73. DP Technology Recent Development Table 74. XtalPi Company Information Table 75. XtalPi Business Overview Table 76. XtalPi Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. XtalPi Molecular Docking and Virtual Screening Software Product Portfolio Table 78. XtalPi Recent Development Table 79. Schrödinger Company Information Table 80. Schrödinger Business Overview Table 81. Schrödinger Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Schrödinger Molecular Docking and Virtual Screening Software Product Portfolio Table 83. Schrödinger Recent Development Table 84. Dassault Systèmes Company Information Table 85. Dassault Systèmes Business Overview Table 86. Dassault Systèmes Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Dassault Systèmes Molecular Docking and Virtual Screening Software Product Portfolio Table 88. Dassault Systèmes Recent Development Table 89. Chemical Computing Group Company Information Table 90. Chemical Computing Group Business Overview Table 91. Chemical Computing Group Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Chemical Computing Group Molecular Docking and Virtual Screening Software Product Portfolio Table 93. Chemical Computing Group Recent Development Table 94. North America Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million) Table 95. North America Molecular Docking and Virtual Screening Software Market Size by Type (2027-2032) & (US$ Million) Table 96. North America Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million) Table 97. North America Molecular Docking and Virtual Screening Software Market Size by Application (2027-2032) & (US$ Million) Table 98. North America Molecular Docking and Virtual Screening Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026) Table 100. North America Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032) Table 101. Europe Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million) Table 102. Europe Molecular Docking and Virtual Screening Software Market Size by Type (2027-2032) & (US$ Million) Table 103. Europe Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million) Table 104. Europe Molecular Docking and Virtual Screening Software Market Size by Application (2027-2032) & (US$ Million) Table 105. Europe Molecular Docking and Virtual Screening Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Europe Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026) Table 107. Europe Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032) Table 108. China Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million) Table 109. China Molecular Docking and Virtual Screening Software Market Size by Type (2027-2032) & (US$ Million) Table 110. China Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million) Table 111. China Molecular Docking and Virtual Screening Software Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million) Table 113. Asia Molecular Docking and Virtual Screening Software Market Size by Type (2027-2032) & (US$ Million) Table 114. Asia Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million) Table 115. Asia Molecular Docking and Virtual Screening Software Market Size by Application (2027-2032) & (US$ Million) Table 116. Asia Molecular Docking and Virtual Screening Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Asia Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026) Table 118. Asia Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032) Table 119. South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million) Table 120. South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Type (2027-2032) & (US$ Million) Table 121. South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million) Table 122. South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Application (2027-2032) & (US$ Million) Table 123. South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026) Table 125. South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032) Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Molecular Docking and Virtual Screening Software Product Image Figure 2. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Molecular Docking and Virtual Screening Software Market Share by Type: 2025 VS 2032 Figure 4. Structure-Based Docking Software Image Figure 5. Ligand-Based Screening Software Image Figure 6. Pharmacophore Screening Software Image Figure 7. Shape and Electrostatic Similarity Software Image Figure 8. AI-Assisted Docking Software Image Figure 9. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Molecular Docking and Virtual Screening Software Market Share by Application: 2025 VS 2032 Figure 11. Hit Discovery Image Figure 12. Lead Optimization Image Figure 13. Drug Repurposing Image Figure 14. Fragment-Based Drug Design Image Figure 15. Target Validation and Mechanism Study Image Figure 16. Teaching and Academic Research Image Figure 17. Global Molecular Docking and Virtual Screening Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 19. Global Molecular Docking and Virtual Screening Software Market Share by Region: 2025 VS 2032 Figure 20. Years Considered Figure 21. Global Molecular Docking and Virtual Screening Software Market Share by Players in 2025 Figure 22. Global Top 5 and 10 Molecular Docking and Virtual Screening Software Players Market Share by Revenue in 2025 Figure 23. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Molecular Docking and Virtual Screening Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Type (2021-2032) Figure 26. Global Molecular Docking and Virtual Screening Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Molecular Docking and Virtual Screening Software Revenue Market Share by Application (2021-2032) Figure 28. North America Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 29. North America Molecular Docking and Virtual Screening Software Market Share by Type (2021-2032) Figure 30. North America Molecular Docking and Virtual Screening Software Market Share by Application (2021-2032) Figure 31. North America Molecular Docking and Virtual Screening Software Market Share by Country (2021-2032) Figure 32. United States Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 33. Canada Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 34. Mexico Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 35. Europe Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 36. Europe Molecular Docking and Virtual Screening Software Market Share by Type (2021-2032) Figure 37. Europe Molecular Docking and Virtual Screening Software Market Share by Application (2021-2032) Figure 38. Europe Molecular Docking and Virtual Screening Software Market Share by Country (2021-2032) Figure 39. Germany Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 40. France Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 41. U.K. Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 42. Italy Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 43. Russia Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 44. Nordic Countries Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 45. China Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 46. China Molecular Docking and Virtual Screening Software Market Share by Type (2021-2032) Figure 47. China Molecular Docking and Virtual Screening Software Market Share by Application (2021-2032) Figure 48. Asia Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 49. Asia Molecular Docking and Virtual Screening Software Market Share by Type (2021-2032) Figure 50. Asia Molecular Docking and Virtual Screening Software Market Share by Application (2021-2032) Figure 51. Asia Molecular Docking and Virtual Screening Software Market Share by Country (2021-2032) Figure 52. Japan Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 53. South Korea Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 54. Taiwan Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 55. Southeast Asia Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 56. India Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 57. Australia Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Share by Type (2021-2032) Figure 60. South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Share by Application (2021-2032) Figure 61. South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Share by Country (2021-2032) Figure 62. Brazil Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 63. South Africa Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 64. Saudi Arabia Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 65. Turkey Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 66. Argentina Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 67. UAE Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 68. Egypt Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 69. Chile Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Structure-Based Docking Software
  • Ligand-Based Screening Software
  • Pharmacophore Screening Software
  • Shape and Electrostatic Similarity Software
  • AI-Assisted Docking Software
Applications
  • Hit Discovery
  • Lead Optimization
  • Drug Repurposing
  • Fragment-Based Drug Design
  • Target Validation and Mechanism Study
  • Teaching and Academic Research
Companies covered
  • OpenEye Cadence Molecular Sciences
  • Cambridge Crystallographic Data Centre
  • Cresset
  • BioSolveIT
  • Molsoft
  • Molecular Discovery
  • DP Technology
  • XtalPi
  • Schrödinger
  • Dassault Systèmes
  • Chemical Computing Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Structure-Based Docking Software
  5. 1.2.3 Ligand-Based Screening Software
  6. 1.2.4 Pharmacophore Screening Software
  7. 1.2.5 Shape and Electrostatic Similarity Software
  8. 1.2.6 AI-Assisted Docking Software
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hit Discovery
  12. 1.3.3 Lead Optimization
  13. 1.3.4 Drug Repurposing
  14. 1.3.5 Fragment-Based Drug Design
  15. 1.3.6 Target Validation and Mechanism Study
  16. 1.3.7 Teaching and Academic Research
  17. 1.4 Global Market Growth Prospects
  18. 1.5 Global Molecular Docking and Virtual Screening Software Growth Trends by Region
  19. 1.5.1 Global Molecular Docking and Virtual Screening Software Market Size by Region: 2021 VS 2025 VS 2032
  20. 1.5.2 Molecular Docking and Virtual Screening Software Market Size by Region (2021-2026)
  21. 1.5.3 Molecular Docking and Virtual Screening Software Market Size by Region (2027-2032)
  22. 1.6 Assumptions and Limitations
  23. 1.7 Study Goals and Objectives
  24. 1.8 Years Considered
2 Global Molecular Docking and Virtual Screening Software Market Dynamics
  1. 2.1 Molecular Docking and Virtual Screening Software Industry Trends
  2. 2.2 Molecular Docking and Virtual Screening Software Industry Drivers
  3. 2.3 Molecular Docking and Virtual Screening Software Industry Opportunities and Challenges
  4. 2.4 Molecular Docking and Virtual Screening Software Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026)
  2. 3.2 Global Molecular Docking and Virtual Screening Software Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Molecular Docking and Virtual Screening Software Key Company Head office and Area Served
  4. 3.4 Global Molecular Docking and Virtual Screening Software Company, Product Type & Application
  5. 3.5 Global Molecular Docking and Virtual Screening Software Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Molecular Docking and Virtual Screening Software Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Molecular Docking and Virtual Screening Software Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Molecular Docking and Virtual Screening Software Tier 1, Tier 2, and Tier 3
4 Molecular Docking and Virtual Screening Software Market by Type
  1. 4.1 Global Molecular Docking and Virtual Screening Software Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Molecular Docking and Virtual Screening Software Market Size by Type (2021-2032)
  3. 4.3 Global Molecular Docking and Virtual Screening Software Market Size Share by Type (2021-2032)
5 Molecular Docking and Virtual Screening Software Market by Application
  1. 5.1 Global Molecular Docking and Virtual Screening Software Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Molecular Docking and Virtual Screening Software Market Size by Application (2021-2032)
  3. 5.3 Global Molecular Docking and Virtual Screening Software Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 OpenEye Cadence Molecular Sciences
  2. 6.1.1 OpenEye Cadence Molecular Sciences Company Information
  3. 6.1.2 OpenEye Cadence Molecular Sciences Business Overview
  4. 6.1.3 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Product Portfolio
  6. 6.1.5 OpenEye Cadence Molecular Sciences Recent Developments
  7. 6.2 Cambridge Crystallographic Data Centre
  8. 6.2.1 Cambridge Crystallographic Data Centre Company Information
  9. 6.2.2 Cambridge Crystallographic Data Centre Business Overview
  10. 6.2.3 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Product Portfolio
  12. 6.2.5 Cambridge Crystallographic Data Centre Recent Developments
  13. 6.3 Cresset
  14. 6.3.1 Cresset Company Information
  15. 6.3.2 Cresset Business Overview
  16. 6.3.3 Cresset Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Cresset Molecular Docking and Virtual Screening Software Product Portfolio
  18. 6.3.5 Cresset Recent Developments
  19. 6.4 BioSolveIT
  20. 6.4.1 BioSolveIT Company Information
  21. 6.4.2 BioSolveIT Business Overview
  22. 6.4.3 BioSolveIT Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 BioSolveIT Molecular Docking and Virtual Screening Software Product Portfolio
  24. 6.4.5 BioSolveIT Recent Developments
  25. 6.5 Molsoft
  26. 6.5.1 Molsoft Company Information
  27. 6.5.2 Molsoft Business Overview
  28. 6.5.3 Molsoft Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Molsoft Molecular Docking and Virtual Screening Software Product Portfolio
  30. 6.5.5 Molsoft Recent Developments
  31. 6.6 Molecular Discovery
  32. 6.6.1 Molecular Discovery Company Information
  33. 6.6.2 Molecular Discovery Business Overview
  34. 6.6.3 Molecular Discovery Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Molecular Discovery Molecular Docking and Virtual Screening Software Product Portfolio
  36. 6.6.5 Molecular Discovery Recent Developments
  37. 6.7 DP Technology
  38. 6.7.1 DP Technology Company Information
  39. 6.7.2 DP Technology Business Overview
  40. 6.7.3 DP Technology Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 DP Technology Molecular Docking and Virtual Screening Software Product Portfolio
  42. 6.7.5 DP Technology Recent Developments
  43. 6.8 XtalPi
  44. 6.8.1 XtalPi Company Information
  45. 6.8.2 XtalPi Business Overview
  46. 6.8.3 XtalPi Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 XtalPi Molecular Docking and Virtual Screening Software Product Portfolio
  48. 6.8.5 XtalPi Recent Developments
  49. 6.9 Schrödinger
  50. 6.9.1 Schrödinger Company Information
  51. 6.9.2 Schrödinger Business Overview
  52. 6.9.3 Schrödinger Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Schrödinger Molecular Docking and Virtual Screening Software Product Portfolio
  54. 6.9.5 Schrödinger Recent Developments
  55. 6.10 Dassault Systèmes
  56. 6.10.1 Dassault Systèmes Company Information
  57. 6.10.2 Dassault Systèmes Business Overview
  58. 6.10.3 Dassault Systèmes Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Dassault Systèmes Molecular Docking and Virtual Screening Software Product Portfolio
  60. 6.10.5 Dassault Systèmes Recent Developments
  61. 6.11 Chemical Computing Group
  62. 6.11.1 Chemical Computing Group Company Information
  63. 6.11.2 Chemical Computing Group Business Overview
  64. 6.11.3 Chemical Computing Group Molecular Docking and Virtual Screening Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Chemical Computing Group Molecular Docking and Virtual Screening Software Product Portfolio
  66. 6.11.5 Chemical Computing Group Recent Developments
7 North America
  1. 7.1 North America Molecular Docking and Virtual Screening Software Market Size (2021-2032)
  2. 7.2 North America Molecular Docking and Virtual Screening Software Market Size by Type
  3. 7.2.1 North America Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026)
  4. 7.2.2 North America Molecular Docking and Virtual Screening Software Market Size by Type (2027-2032)
  5. 7.2.3 North America Molecular Docking and Virtual Screening Software Market Share by Type (2021-2032)
  6. 7.3 North America Molecular Docking and Virtual Screening Software Market Size by Application
  7. 7.3.1 North America Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026)
  8. 7.3.2 North America Molecular Docking and Virtual Screening Software Market Size by Application (2027-2032)
  9. 7.3.3 North America Molecular Docking and Virtual Screening Software Market Share by Application (2021-2032)
  10. 7.4 North America Molecular Docking and Virtual Screening Software Market Size by Country
  11. 7.4.1 North America Molecular Docking and Virtual Screening Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026)
  13. 7.4.3 North America Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032)
  14. 7.4.4 North America Molecular Docking and Virtual Screening Software Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Molecular Docking and Virtual Screening Software Market Size (2021-2032)
  2. 8.2 Europe Molecular Docking and Virtual Screening Software Market Size by Type
  3. 8.2.1 Europe Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026)
  4. 8.2.2 Europe Molecular Docking and Virtual Screening Software Market Size by Type (2027-2032)
  5. 8.2.3 Europe Molecular Docking and Virtual Screening Software Market Share by Type (2021-2032)
  6. 8.3 Europe Molecular Docking and Virtual Screening Software Market Size by Application
  7. 8.3.1 Europe Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026)
  8. 8.3.2 Europe Molecular Docking and Virtual Screening Software Market Size by Application (2027-2032)
  9. 8.3.3 Europe Molecular Docking and Virtual Screening Software Market Share by Application (2021-2032)
  10. 8.4 Europe Molecular Docking and Virtual Screening Software Market Size by Country
  11. 8.4.1 Europe Molecular Docking and Virtual Screening Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026)
  13. 8.4.3 Europe Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032)
  14. 8.4.4 Europe Molecular Docking and Virtual Screening Software Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Molecular Docking and Virtual Screening Software Market Size (2021-2032)
  2. 9.2 China Molecular Docking and Virtual Screening Software Market Size by Type
  3. 9.2.1 China Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026)
  4. 9.2.2 China Molecular Docking and Virtual Screening Software Market Size by Type (2027-2032)
  5. 9.2.3 China Molecular Docking and Virtual Screening Software Market Share by Type (2021-2032)
  6. 9.3 China Molecular Docking and Virtual Screening Software Market Size by Application
  7. 9.3.1 China Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026)
  8. 9.3.2 China Molecular Docking and Virtual Screening Software Market Size by Application (2027-2032)
  9. 9.3.3 China Molecular Docking and Virtual Screening Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Molecular Docking and Virtual Screening Software Market Size (2021-2032)
  2. 10.2 Asia Molecular Docking and Virtual Screening Software Market Size by Type
  3. 10.2.1 Asia Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026)
  4. 10.2.2 Asia Molecular Docking and Virtual Screening Software Market Size by Type (2027-2032)
  5. 10.2.3 Asia Molecular Docking and Virtual Screening Software Market Share by Type (2021-2032)
  6. 10.3 Asia Molecular Docking and Virtual Screening Software Market Size by Application
  7. 10.3.1 Asia Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026)
  8. 10.3.2 Asia Molecular Docking and Virtual Screening Software Market Size by Application (2027-2032)
  9. 10.3.3 Asia Molecular Docking and Virtual Screening Software Market Share by Application (2021-2032)
  10. 10.4 Asia Molecular Docking and Virtual Screening Software Market Size by Country
  11. 10.4.1 Asia Molecular Docking and Virtual Screening Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026)
  13. 10.4.3 Asia Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032)
  14. 10.4.4 Asia Molecular Docking and Virtual Screening Software Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Molecular Docking and Virtual Screening Software Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research